Australia markets closed

XORTX Therapeutics Inc. (XRTX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.4999+0.0699 (+2.88%)
At close: 04:00PM EDT
2.5000 +0.00 (+0.00%)
After hours: 05:39PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
2,527
-2,158
-6,989
-1,296
-1,007
Depreciation & amortisation
50.762
139.694
55.4583
14.0249
16.0286
Stock-based compensation
679.797
120.984
466.0684
391.4903
230.1225
Change in working capital
1,312
-1,031
1,449
-1,080
284.0538
Accounts receivable
-72.195
21.041
-43.6126
-29.1666
0
Other working capital
-10,820
-6,630
-8,863
-4,786
-582.4767
Other non-cash items
-
-
3.7017
58.8226
0.6634
Net cash provided by operating activities
-10,765
-6,583
-8,818
-4,755
-571.2232
Cash flows from investing activities
Investments in property, plant and equipment
-55.362
-46.363
-44.2205
-31.2223
-11.2535
Net cash used for investing activities
-55.362
-46.363
-44.2205
-31.2223
-11.2535
Cash flows from financing activities
Debt repayment
-66.089
-66.089
-40.6167
0
0
Common stock issued
16,677
0
5,051
17,881
705.7938
Other financing activities
-733.284
-295.251
-272.3313
-671.4506
-34.9697
Net cash used provided by (used for) financing activities
16,855
-361.044
4,738
19,181
670.8241
Net change in cash
7,162
-6,987
-3,482
14,651
88.3473
Cash at beginning of period
4,998
10,434
13,890
134.3281
45.966
Cash at end of period
11,032
3,448
10,408
14,785
134.3133
Free cash flow
Operating cash flow
-10,765
-6,583
-8,818
-4,755
-571.2232
Capital expenditure
-55.362
-46.363
-44.2205
-31.2223
-11.2535
Free cash flow
-10,820
-6,630
-8,863
-4,786
-582.4767